FMS

Fresenius Medical Care

FMS • NYSE

Fresenius Medical Care is a publicly traded company trading on NYSE, led by CEO Helen Giza.

CEOHelen Giza
Employees119.8K
Websitefreseniusmedicalcare.com

Next Earnings

Upcoming earnings announcement for Fresenius Medical Care

Date
Tuesday, May 5, 2026 (in a month)
Timing
Before Market Open (7:00 AM New York)
Fiscal Period
Q1 2026
EPS Estimate
$0.54
Revenue Estimate
$5.5B

Earnings History

Past 12 earnings reports for Fresenius Medical Care

DatePeriodEPSEPS SurpriseRevenueRev. SurpriseFiling
Feb 24, 2026Q4 2025
$0.84Est: $0.67
+25.4%
$5.9BEst: $5.9B
+0.4%—
Nov 4, 2025Q3 2025
$0.64Est: $0.59
+8.5%
$5.7BEst: $5.5B
+4.2%—
Aug 5, 2025Q2 2025
$0.52Est: $0.50
+4.0%
$5.3BEst: $5.4B
-0.6%—
May 6, 2025Q1 2025
$0.44Est: $0.38
+15.8%
$5.1BEst: $4.7B
+8.3%—
Feb 25, 2025Q4 2024
$0.49Est: $0.40
+22.5%
$5.4BEst: $5.5B
-2.0%—
Nov 5, 2024Q3 2024
$0.45Est: $0.38
+18.4%
$5.2BEst: $5.3B
-1.7%—
Jul 30, 2024Q2 2024
$0.38Est: $0.37
+1.9%
$5.1BEst: $5.2B
-1.7%—
May 7, 2024Q1 2024
$0.36Est: $0.26
+39.6%
$5.1BEst: $5.1B
+1.0%—
Feb 20, 2024Q4 2023
$0.47Est: $0.32
+48.1%
$5.4BEst: $5.4B
+0.4%—
Nov 1, 2023Q3 2023
$0.31Est: $0.33
-6.1%
$5.4BEst: $5.3B
+1.8%—
Aug 2, 2023Q2 2023
$0.32Est: $0.24
+33.3%
$5.3BEst: $5.2B
+1.3%—
May 9, 2023Q1 2023
$0.28Est: $0.13
+115.4%
$5.0BEst: $5.3B
-5.3%—
View all filings on SEC EDGAR

Cookie Preferences

We use cookies for analytics. See our Privacy and Cookie Policy.